LENZ Therapeutics ( NASDAQ: LENZ ) said it is looking to raise $30M through a stock purchase agreement with Ridgeback Capital Investments. Shares in the company were up 7% in premarket trade. The firm intends to use the net proceeds along with its existing cash, cash equivalents, and marketable securities, to support the regulatory, pre-commercial and potential commercial launch activities for LNZ100 as well as for working capital and general corporate purposes.
More on LENZ Therapeutics, Inc. LENZ Therapeutics, Inc. (LENZ) Q1 2024 Earnings Call Transcript Historical earnings data for LENZ Therapeutics, Inc.
Financial information for LENZ Therapeutics, Inc..